Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Cohort studies have reported that midlife high total serum cholesterol (TC) is associated with increased risk of Alzheimer’s disease (AD) in late-life but findings have been based on few studies and previous reviews have been limited by a lack of compatible data. Objective: We synthesized all high quality data from cohort studies reporting on the association between total serum cholesterol measured and late-life cognitive outcomes including Alzheimer’s disease (AD), vascular dementia (VaD), any dementia, mild cognitive impairment (MCI), and cognitive decline. Methods: The literature was searched up to October 2016 using a registered protocol. Thirty-four articles meeting study criteria were identified. Seventeen studies published from 1996 to 2014, including 23,338 participants were included in meta-analyses. Results: Relative risk of developing AD for adults with high TC in midlife was 2.14 (95% CI 1.33–3.44) compared with normal cholesterol. Individual studies that could not be pooled also reported high TC in midlife increased the risk of MCI and cognitive decline in late-life. High TC in late-life was not associated with MCI, AD, VaD, any dementia, or cognitive decline. Late-life measured HDL cholesterol and triglycerides were not associated with increased risk of VaD, and HDL was not associated with risk of MCI, AD, or any dementia. There were insufficient data to examine other cholesterol sub-fractions, sex differences, or APOE interactions. Conclusions: Significant gaps in the literature regarding TC and late-life dementia remain. Evidence suggests that high midlife TC increases risk of late-life AD, and may correlate with the onset of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analytic evidence found inconsistent evidence from HICs that high LDL-C in midlife, but not in later life, might be a risk factor for cognitive decline, all cause dementia and AD.”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [151]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, midlife obesity, 105,111,112 hypertension, 85,[105][106][107] prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) 85 and high cholesterol 113 are associated with an increased risk of dementia in later life.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [113]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“If there was evidence of heterogeneity and four or more studies were available, random effects meta-analysis was used [18, 19].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Heterogeneity among studies was examined using standard I2 which estimates the proportion of variance due to heterogeneity [16].”
MethodPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“MATERIALS AND METHODS Registration of protocol and reporting The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO CRD42015026727) [6] and reported in accordance with the PRISMA checklist [7].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 2×
“Additional quality ratings were conducted for all studies meeting criteria using a checklist adapted from previous reviews, and the Newcastle Ottawa scale [8, 9].”
BackgroundMethodBorenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“However, studies publishing on midlife lacked clear information on the age range of the sample at baseline and the distribution of the sample within midlife and late-life [12, 21].”
BackgroundThe nuts and bolts of PROSPERO: an international prospective register of systematic reviews
Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-2 · Cited by 1,433 · cited 2×
“The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO CRD42015026727) [6] and reported in accordance with the PRISMA checklist [7].”
MethodKivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126 · cited 1×
“Lipid measures including high density lipoproteins (HDL) and TC in midlife are currently used in assessment tools that evaluate risk of AD and dementia [3, 4].”
MethodYoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Vascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530 · cited 1×
“Nine European and US studies had compatible data and from that we estimated the correlation between year of observation and sample average TC which was –0.66, p = 0.05 and review of the data suggests a decline in baseline cholesterol levels over time.”
InfluentialStatins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Pedditizi, E., Peters, R., & Beckett, N. (2016) · Age and Ageing · doi:10.1093/ageing/afv151 · Cited by 474
Self-citationAnstey, K. J., Lipnicki, D. M., & Low, L.-F. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000310778.20870.ae · Cited by 437
Self-citationHigh total cholesterol levels in late life associated with a reduced risk of dementia
Mielke, M. M., Zandi, P. P., Sjögren, M., Gustafson, D., Östling, S., Steen, B., & Skoog, I. (2005) · Neurology · doi:10.1212/01.wnl.0000161870.78572.a5 · Cited by 411 · cited 1×
“Three studies [22, 23, 26] with 5,467 participants reported compatible data on TC in late-life and any dementia.”
BackgroundRelation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · cited 7×
“Two studies reported compatible data on HDL-C and triglycerides in late-life and risk of VaD [24, 29], including a total of 10,558 participants and when pooled, found no association.”
BackgroundResultInfluentialMetabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia
Raffaitin, C., Gin, H., Empana, J.-P., Helmer, C., Berr, C., Tzourio, C., Portet, F., Dartigues, J.-F., Alpérovitch, A., & Barberger-Gateau, P. (2009) · Diabetes Care · doi:10.2337/dc08-0272 · Cited by 337
Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function
Yaffe, K., Vittinghoff, E., Pletcher, M. J., Hoang, T. D., Launer, L. J., Whitmer, R. A., Coker, L. H., & Sidney, S. (2014) · Circulation · doi:10.1161/circulationaha.113.004798 · Cited by 308
Risk profiles for mild cognitive impairment and progression to dementia are gender specific
Artero, S., Ancelin, M.-L., Portet, F., Dupuy, A., Berr, C., Dartigues, J.-F., Tzourio, C., Rouaud, O., Poncet, M., Pasquier, F., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136903 · Cited by 281 · cited 10×
“Dementia and cognition terms included: Cognit*, Memory, Attention, Reaction time, Speed of processing, Processing speed, Crystallized ability, Crystallized intelligence, Fluid ability, Fluid intelligence, General mental ability, GMA, Intelligence, Executive function, Neuropsychological testing, Mini mental stat* exam*…”
BackgroundInfluentialPlasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study
Tan, Z. S., Seshadri, S., Beiser, A., Wilson, P. W. F., Kiel, D. P., Tocco, M., D'Agostino, R. B., & Wolf, P. A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1053 · Cited by 280 · cited 2×
“A report examining averageTCover timefrommid- to late-lifeasapredictor of late-life AD in the Framingham study found no associationofTCwithADbut this studydidnotmodel trajectories [52].”
BackgroundPedditzi, E., Peters, R., & Beckett, N. (2016) · Age and Ageing · doi:10.1093/ageing/afw095 · Cited by 279 · cited 1×
“Additional quality ratings were conducted for all studies meeting criteria using a checklist adapted from previous reviews, and the Newcastle Ottawa scale [8, 9].”
MethodSelf-citationDanaei, G., Singh, G. M., Paciorek, C. J., Lin, J. K., Cowan, M. J., Finucane, M. M., Farzadfar, F., Stevens, G. A., Riley, L. M., Lu, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001470 · Cited by 249
Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke
Moroney, J. T. (1999) · JAMA · doi:10.1001/jama.282.3.254 · Cited by 222 · cited 1×
“A final study found high LDL-C was associated with increased risk of dementia with stroke [39].”
BackgroundReitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.297 · Cited by 205 · cited 2×
“Three studies [22, 24, 25] (n = 6,062) reported compatible data on HDL-C in late-life and AD and found no association.”
BackgroundResultApolipoprotein E and cognitive change in an elderly population
Hyman, B. T., Gomez‐Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., & Wallace, R. (1996) · Annals of Neurology · doi:10.1002/ana.410400111 · Cited by 205 · cited 1×
“Two studies [30, 32] with 2,521 participants reported compatible data on TC in late-life and cognitive decline and found no association.”
BackgroundA summary risk score for the prediction of Alzheimer disease in elderly persons
Reitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.136 · Cited by 199 · cited 1×
“Lipid measures including high density lipoproteins (HDL) and TC in midlife are currently used in assessment tools that evaluate risk of AD and dementia [3, 4].”
MethodStewart, R., White, L. R., Xue, Q.-L., & Launer, L. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.103 · Cited by 191 · cited 3×
“Studies reporting results for models incorporating multiple measures of cholesterol over long follow-up periods Four studies using different methodologies have characterized TC over multiple occasions of measurement with long follow-up periods [2, 21, 51, 52].”
BackgroundOxidized cholesterol as the driving force behind the development of Alzheimer’s disease
Gamba, P., Testa, G., Gargiulo, S., Staurenghi, E., Poli, G., & Leonarduzzi, G. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00119 · Cited by 180 · cited 1×
“Animal studies have shown that intervention with a high cholesterol diet leads to memory deficits, increases oxidative stress and doubles the concentration of amyloid- in the hippocampus [55].”
BackgroundThacker, E. L., Gillett, S. R., Wadley, V. G., Unverzagt, F. W., Judd, S. E., McClure, L. A., Howard, V. J., & Cushman, M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000635 · Cited by 169 · cited 1×
“Two individual studies showed that high TC in midlife [49] or mid- to late-life was associated with an increased risk of cognitive decline [48] and another study reported an association of high midlife TC and risk of MCI in late-life [49].”
BackgroundThe 32-year relationship between cholesterol and dementia from midlife to late life
Mielke, M. M., Zandi, P. P., Shao, H., Waern, M., Östling, S., Guo, X., Björkelund, C., Lissner, L., Skoog, I., & Gustafson, D. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb2bf · Cited by 160 · cited 3×
“Two studies reported compatible data on TC in midlife and late-life dementia [21, 27] including 3,392 participants but found no association.”
BackgroundKalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1996) · Stroke · doi:10.1161/01.str.27.12.2230 · Cited by 160 · cited 1×
“One study reported on the association of HDL-C and cognitive decline and found no association [50] and two reported data with long-term follow-ups and are described below [51, 53].”
BackgroundSerum cholesterol and risk of Alzheimer disease: A community-based cohort study
Li, G., Shofer, J. B., Kukull, W. A., Peskind, E. R., Tsuang, D. W., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., Schellenberg, G. D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000178989.87072.11 · Cited by 159
Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women
Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Helkala, E.-L., Haapala, I., Nissinen, A., & Rauramaa, R. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096636 · Cited by 156 · cited 16×
“Two studies reported compatible data on HDL-C and triglycerides in late-life and risk of VaD [24, 29], including a total of 10,558 participants and when pooled, found no association.”
BackgroundInfluentialStatins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150
Impact of plasma lipids and time on memory performance in healthy elderly without dementia
Reitz, C., Luchsinger, J., Tang, M. X., Manly, J., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000158274.31318.3c · Cited by 126 · cited 1×
“A report from the Three Cities study in France found high TC in late-life was not associated with increased risk of MCI [45] and two more studies from the US found no association of late-life TC, triglycerides, or LDL and memory or cognitive decline [35, 46].”
BackgroundThe Effect of Cardiorespiratory Fitness on Age-Related Lipids and Lipoproteins
Park, Y., Sui, X., Liu, J., Zhou, H., Kokkinos, P. F., Lavie, C. J., Hardin, J. W., & Blair, S. N. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.517 · Cited by 122 · cited 1×
“This provides further reason to promote lifestyle changes associated with improvements in body composition [59] and exercise [60].”
BackgroundStatins and serum cholesterol's associations with incident dementia and mild cognitive impairment
Beydoun, M. A., Beason‐Held, L. L., Kitner‐Triolo, M. H., Beydoun, H. A., Ferrucci, L., Resnick, S. M., & Zonderman, A. B. (2010) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2009.100826 · Cited by 115 · cited 5×
“However, studies publishing on midlife lacked clear information on the age range of the sample at baseline and the distribution of the sample within midlife and late-life [12, 21].”
BackgroundResultInfluentialPiguet, O., Grayson, D. A., Creasey, H., Bennett, H. P., Brooks, W. S., Waite, L. M., & Broe, G. A. (2003) · Neuroepidemiology · doi:10.1159/000069886 · Cited by 100 · cited 1×
“An early Australian study of late-life high TC as a predictor of dementia observed a small protective effect but did not include covariates [44].”
BackgroundPlasma Lipid Levels in the Elderly Are Not Associated with the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Schupf, N., Mayeux, R., & Luchsinger, J. A. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000115847 · Cited by 95 · cited 12×
“Dementia and cognition terms included: Cognit*, Memory, Attention, Reaction time, Speed of processing, Processing speed, Crystallized ability, Crystallized intelligence, Fluid ability, Fluid intelligence, General mental ability, GMA, Intelligence, Executive function, Neuropsychological testing, Mini mental stat* exam*…”
BackgroundResultInfluentialLinking perceived control, physical activity, and biological health to memory change.
Infurna, F. J., & Gerstorf, D. (2013) · Psychology and Aging · doi:10.1037/a0033327 · Cited by 90 · cited 1×
“An examination of the Health and Retirement Study data on a sample including both mid- and older-aged adults reported that HDL-C mediated the association between lifestyle variables and memory decline [37].”
BackgroundRomán, G. C. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.106.s178.2.x · Cited by 84 · cited 1×
“, NINDS–AIREN criteria for the diagnosis of vascular dementia [15]).”
MethodSex Differences in the Associations Between Lipid Levels and Incident Dementia
Ancelin, M.-L., Ripoche, E., Dupuy, A.-M., Barberger-Gateau, P., Auriacombe, S., Rouaud, O., Berr, C., Carrière, I., & Ritchie, K. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121228 · Cited by 82 · cited 2×
“One study found opposite effects of low triglycerides, with increased risk for males and reduced risk for females [20].”
BackgroundThe Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 80 · cited 1×
“INTRODUCTION The link between cholesterol and Alzheimer’s disease (AD) is supported by the identification of clusters of genes (apolipoprotein E4, single-nucleotide polymorphisms for clusterin (CLU), ABCA7, and PICALM) that influence lipid binding and metabolism in the brain [1].”
BackgroundTaniguchi, Y., Shinkai, S., Nishi, M., Murayama, H., Nofuji, Y., Yoshida, H., & Fujiwara, Y. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt286 · Cited by 71 · cited 1×
“Two studies [30, 32] with 2,521 participants reported compatible data on TC in late-life and cognitive decline and found no association.”
BackgroundThe effect of apoE on dementia is not through atherosclerosis: The Rotterdam Study
Knittweis, J. W., McMullen, W. A., Romas, S. N., Mayeux, R., Slooter, A. J. C., Ruitenberg, A., van Duijn, C. M., Breteler, M. M. B., & Liu, H. C. (2000) · Neurology · doi:10.1212/wnl.54.12.2356-a · Cited by 61
Cholesterol in mild cognitive impairment and Alzheimer’s disease in a birth cohort over 14 years
Toro, P., Degen, C., Pierer, M., Gustafson, D., Schröder, J., & Schönknecht, P. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0468-2 · Cited by 54 · cited 2×
“Declining TC is observed retrospectively in patients who eventually develop AD in cohort studies [31], implicating high TC as a risk factor or possible biomarker of emerging AD, very early in the disease process.”
BackgroundKarlamangla, A. S., Singer, B. H., Reuben, D. B., & Seeman, T. E. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52152.x · Cited by 46 · cited 1×
“One study [36] found that an improvement in the profile of non-HDL-C in high functioning older adults (n = 1189) followed for 4.”
BackgroundCognitive decline precedes late-life longitudinal changes in vascular risk factors
van Vliet, P., Westendorp, R. G. J., van Heemst, D., de Craen, A. J. M., & Oleksik, A. M. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.182519 · Cited by 46
The effect of APOE on dementia is not through atherosclerosis: The Rotterdam Study
Slooter, A. J. C., Cruts, M., Ott, A., Bots, M. L., Witteman, J. C. M., Hofman, A., Broeckhoven, C. V., Breteler, M. M. B., & van Duijn, C. M. (1999) · Neurology · doi:10.1212/wnl.53.7.1593 · Cited by 41
Mielke, M. M., Xue, Q., Zhou, J. Q., Chaves, P. H. M., Fried, L. P., & Carlson, M. C. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.6.619 · Cited by 33 · cited 2×
“A report from the Three Cities study in France found high TC in late-life was not associated with increased risk of MCI [45] and two more studies from the US found no association of late-life TC, triglycerides, or LDL and memory or cognitive decline [35, 46].”
BackgroundPower, C., Jefferis, B. J. M. H., & Manor, O. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.155564 · Cited by 30 · cited 1×
“In addition, early life social-disadvantage may impact on midlife risk factors and confound associations observed between risk factors and late-life cognitive outcomes [54].”
BackgroundNonlinear longitudinal trajectories of cholesterol and neuropsychological function.
Wendell, C. R., Waldstein, S. R., & Zonderman, A. B. (2013) · Neuropsychology · doi:10.1037/neu0000002 · Cited by 29
Insulin-Like Growth Factor-I Receptor Stimulating Activity is Associated with Dementia
de Bruijn, R. F. A. G., Janssen, J. A. M. J. L., Brugts, M. P., van Duijn, C. M., Albert Hofman, D., Koudstaal, P. J., & Ikram, M. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140186 · Cited by 26
Late-life alcohol consumption and cognitive function in elderly men
Hogenkamp, P. S., Benedict, C., Sjögren, P., Kilander, L., Lind, L., & Schiöth, H. B. (2013) · AGE · doi:10.1007/s11357-013-9538-7 · Cited by 22
Liao, P.-J., Xie, R.-B., Yin, R., Wei, D.-X., Huang, J., Huang, F., Li, H., Lin, W., Wu, J., & Pan, S. (2015) · PubMed · Cited by 16
Mertens, E., Clarys, P., Lefevre, J., Charlier, R., Knaeps, S., & Deforche, B. I. (2015) · Journal of Physical Activity and Health · doi:10.1123/jpah.2015-0378 · Cited by 9 · cited 1×
“This provides further reason to promote lifestyle changes associated with improvements in body composition [59] and exercise [60].”
Background
Research works printed but not linked: 4
- 2005, Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]
- Slooter AJC, 2000, Neurology, 54, 2357
- Liao PJ, 2015, Int J Clin Exp Med, 8, 19200
- McGuinness B, 2016, Cochrane Database Syst Rev, 1, CD003160
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
Malm, C., Jakobsson, J., & Isaksson, A. (2019) · Sports · doi:10.3390/sports7050127 · Cited by 610
“I proved blood lipid profile [93] Lower risk for cardi pul onary disease in elderly [94,95] and Alzheimer’s [96] No effect on blood lipid profiles in children and adolescents [97] Improved peripheral nerve function [98] Better coordination, balance and reaction [98,99], especially in children and elderly [100] Enhance…”
BackgroundInfluential
Metadata
- Authors
- Anstey, K. J., Ashby-Mitchell, K., & Peters, R.
- Affiliations
- Australian National University (AU)
- Corresponding author
- Anstey, Kaarin J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-11-29
- Volume
- 56
- Issue
- 1
- Pages
- 215-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5240556
- OpenAlex
- W2558803774
- Semantic Scholar
- 0c1251803f118cf5e382bfc6624ab0fbd3c53d8f
- Cited by
- 360
- References
- 61
- Citations by year
- 2026: 18 · 2025: 42 · 2024: 52 · 2023: 43 · 2022: 52 · 2021: 51 · 2020: 43 · 2019: 34 · 2018: 18 · 2017: 7
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- ANU Open Research (Australian National University) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Research (PDF-2012-05-197)
- National Health and Medical Research Council (1002560)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- serum cholesterol
- MeSH terms
- Alzheimer Disease, Cholesterol, Dementia, Humans, Risk Factors, Cohort Studies, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
